SG11202106207VA - A digital therapeutic component to optimize induction of buprenorphine-containing products - Google Patents

A digital therapeutic component to optimize induction of buprenorphine-containing products

Info

Publication number
SG11202106207VA
SG11202106207VA SG11202106207VA SG11202106207VA SG11202106207VA SG 11202106207V A SG11202106207V A SG 11202106207VA SG 11202106207V A SG11202106207V A SG 11202106207VA SG 11202106207V A SG11202106207V A SG 11202106207VA SG 11202106207V A SG11202106207V A SG 11202106207VA
Authority
SG
Singapore
Prior art keywords
buprenorphine
containing products
therapeutic component
digital therapeutic
optimize induction
Prior art date
Application number
SG11202106207VA
Inventor
Hilary Luderer
Nicole Enman
Audrey Kern
Jake Nichols
Yuri Maricich
Original Assignee
Pear Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pear Therapeutics Inc filed Critical Pear Therapeutics Inc
Publication of SG11202106207VA publication Critical patent/SG11202106207VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022Monitoring a patient using a global network, e.g. telephone networks, internet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02444Details of sensor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4833Assessment of subject's compliance to treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0257Proximity sensors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Physiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • General Business, Economics & Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
SG11202106207VA 2018-12-14 2019-12-16 A digital therapeutic component to optimize induction of buprenorphine-containing products SG11202106207VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862779705P 2018-12-14 2018-12-14
PCT/US2019/066509 WO2020124073A1 (en) 2018-12-14 2019-12-16 A digital therapeutic component to optimize induction of buprenorphine-containing products

Publications (1)

Publication Number Publication Date
SG11202106207VA true SG11202106207VA (en) 2021-07-29

Family

ID=71073790

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202106207VA SG11202106207VA (en) 2018-12-14 2019-12-16 A digital therapeutic component to optimize induction of buprenorphine-containing products

Country Status (10)

Country Link
US (1) US20200187777A1 (en)
EP (1) EP3895173A4 (en)
JP (1) JP2022512230A (en)
KR (1) KR20210114940A (en)
CN (1) CN113811950A (en)
AU (1) AU2019396627A1 (en)
CA (1) CA3122430A1 (en)
IL (1) IL283747A (en)
SG (1) SG11202106207VA (en)
WO (1) WO2020124073A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112652372A (en) * 2019-10-10 2021-04-13 P·艾伦比 Apparatus and method for patient drug administration and titration of medication prescribed and monitored by a physician
KR20230024378A (en) 2020-06-12 2023-02-20 벡클리 싸이테크 리미티드 A composition comprising the benzoate salt of 5-methoxy-N,N-dimethyltryptamine
US11986472B1 (en) 2020-06-30 2024-05-21 Orexo Ab Method of controlling alcohol consumption in subjects treated for opioid dependence
US11617746B1 (en) 2020-06-30 2023-04-04 Orexo Ab Method of controlling depression in subjects treated for opioid dependence
US20230148863A1 (en) * 2021-11-17 2023-05-18 Rekovar, Inc. System for identifying and remediating patient withdrawal symptoms
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
DE19709704C2 (en) * 1997-03-10 1999-11-04 Michael Georgieff Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia
ES2310262T3 (en) * 2002-12-13 2009-01-01 Euro-Celtique S.A. DOSAGE REGIME OF TRANSDERMIC BRUPRENORPHINE FOR ANALGESIA.
US20080199407A1 (en) * 2007-02-15 2008-08-21 Slater Kenneth C Drug Detoxification Protocol Using Microdosing
US8138169B2 (en) * 2008-04-11 2012-03-20 Comgenrx, Inc. Combination therapy for bipolar disorder
US20130071463A1 (en) * 2009-11-17 2013-03-21 Maria Palasis Implants for postoperative pain
EP2685898B1 (en) * 2011-03-18 2022-09-07 Sanofi-Aventis Deutschland GmbH Calculating a medicament dose
US8810408B2 (en) * 2011-04-04 2014-08-19 Alarm.Com Incorporated Medication management and reporting technology
US20140257014A1 (en) * 2013-03-07 2014-09-11 Medrad, Inc. Treadmill automated dosing user interface
US10321870B2 (en) * 2014-05-01 2019-06-18 Ramot At Tel-Aviv University Ltd. Method and system for behavioral monitoring
EP3215223B1 (en) * 2014-11-07 2020-07-01 Indivior UK Limited Buprenorphine dosing regimens
WO2017089317A1 (en) * 2015-11-23 2017-06-01 Koninklijke Philips N.V. Pulse oximeter integration for evaluating and updating a drug administration schedule using effectiveness rating
CN108475534A (en) * 2015-12-31 2018-08-31 皇家飞利浦有限公司 Virtual infusion pump
US11039986B2 (en) * 2016-02-25 2021-06-22 Samsung Electronics Co., Ltd. Chronotherapeutic dosing of medication and medication regimen adherence
CA3035822A1 (en) * 2016-09-28 2018-04-05 Chrono Therapeutics Inc. Transdermal drug delivery device for delivering opioids
US20180294049A1 (en) * 2017-04-05 2018-10-11 ROCA Medical Ltd. Opiate reduction treatment system
KR102660711B1 (en) * 2017-10-20 2024-04-26 키에시 파르마슈티시 엣스. 피. 에이. Pharmaceutical preparations comprising an opioid receptor agonist as an active ingredient, methods for their preparation and therapeutic use

Also Published As

Publication number Publication date
US20200187777A1 (en) 2020-06-18
AU2019396627A1 (en) 2021-07-15
EP3895173A4 (en) 2022-08-17
CN113811950A (en) 2021-12-17
IL283747A (en) 2021-07-29
WO2020124073A1 (en) 2020-06-18
EP3895173A1 (en) 2021-10-20
CA3122430A1 (en) 2020-06-18
JP2022512230A (en) 2022-02-02
KR20210114940A (en) 2021-09-24

Similar Documents

Publication Publication Date Title
IL283747A (en) A digital therapeutic component to optimize induction of buprenorphine-containing products
PL3102673T3 (en) Methods and compositions for treatment of a beta thalessemia
GB2575291B (en) Gateway to Gateway Synchronisation
EP3368553A4 (en) Polymer-based therapeutics for inductive browning of fat
IL291195A (en) Compounds for the induction of antigen-specific immune tolerance
EP2918262C0 (en) Induction of antigen-specific tolerance by peripheral phagocytosis
IL266087A (en) Use of itolizumab to reduce phosphorylation of cd6
PL3258969T3 (en) Immunoconjugates for specific induction of t cell cytotoxicity against a target cell
PL3242564T3 (en) Method of producing smooth shelf-stable products
SG11202008170RA (en) Multiplier-accumulator
IL249021B (en) Fully-digital fully-synthesizable delay-line analog to digital converter
GB201721657D0 (en) Digital to analogue conversion
GB201906176D0 (en) Gating of radiotherepy
EP3341169C0 (en) Method of forming a ceramic product
GB201815483D0 (en) Therapeutic bacteriophages
ZA201801284B (en) Production of form coke
PL3524231T3 (en) Stabilized preparation of interferon beta variant
EP3362420C0 (en) A method of forming a ceramic product
GB2583579B (en) Echo cancellation for time of flight analogue to digital converter
GB2584544B (en) Improvements to letter-plates
CZ34320U1 (en) A set of food supplements
PT3901141T (en) Novel form of isoquinolinesulfonamide
GB201817765D0 (en) Slim theory to fat
IL289338A (en) Therapeutic interactions of leucomethylthioninium
ZAF201800948S (en) Set of covers